Skip to main content
SpringerLink
Log in

Behandlung des fortgeschrittenen Adenokarzinoms der Speiseröhre

Neoadjuvante Chemotherapie oder Chemoradiotherapie?

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Stahl M et al. J Clin Oncol. 2009;27(6):851–6.

    Article  CAS  PubMed  Google Scholar 

  2. Favi F et al. Eur J Surg Oncol. 2017;43(8):1572–80.

    Article  CAS  PubMed  Google Scholar 

  3. Stahl M et al. Eur J Cancer. 2017;81:183–90.

    Article  CAS  PubMed  Google Scholar 

  4. Hong YS et al. Lancet Oncol. 2014;15(11):1245–53.

    Article  CAS  PubMed  Google Scholar 

  5. Klautke G. Strahlenther Onkol. 2017;(in press)

Originalie

  • Favi F et al. Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study. Eur J Surg Oncol. 2017;43(8):1572–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Radioonkologie am Klinikum Chemnitz, Chemnitz, Deutschland

    Gunther Klautke

Authors
  1. Gunther Klautke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gunther Klautke.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klautke, G. Neoadjuvante Chemotherapie oder Chemoradiotherapie?. Info Onkol. 20, 32–33 (2017). https://doi.org/10.1007/s15004-017-5849-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-017-5849-7

Schlüsselwörter

Search

Navigation